You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

deucravacitinib

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lichen Planopilaris Trial in Scottsdale, Jacksonville (Deucravacitinib)

Not yet recruiting
  • Lichen Planopilaris
  • Deucravacitinib
  • Scottsdale, Arizona
  • +1 more
Oct 16, 2023

Palmoplantar Pustulosis Trial (Deucravacitinib)

Not yet recruiting
  • Palmoplantar Pustulosis
  • Deucravacitinib
  • (no location specified)
Feb 1, 2023

Pyoderma Gangrenosum Trial in Lebanon (Deucravacitinib)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Deucravacitinib
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Apr 6, 2023

Inflammatory Epidermal Genodermatoses Trial in Nice (deucravacitinib)

Not yet recruiting
  • Inflammatory Epidermal Genodermatoses
  • deucravacitinib
  • Nice, Chu de Nice, France
    DRCI
Nov 24, 2023

Psoriasis Vulgaris Trial in San Francisco (deucravacitinib)

Not yet recruiting
  • Psoriasis Vulgaris
  • deucravacitinib
  • San Francisco, California
    University of California, San Francisco
May 4, 2023

Plaque Psoriasis Trial (JNJ-77242113, JNJ-77242113 Matching Placebo, Deucravacitinib)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Nov 16, 2023

Deucravacitinib in Moderate-to-Severe Plaque Psoriasis in

Recruiting
  • Plaque Psoriasis
  • Deucravacitinib
  • Selters, Rhineland-Palatinate, Germany
    Dermatologische Spezial- und Schwerpunktpraxis Selters
Oct 23, 2023

Hidradenitis Suppurativa Trial in Boston (Deucravacitinib, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • Deucravacitinib
  • Placebo
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 10, 2023

Nail Psoriasis Trial (Deucravacitinib)

Not yet recruiting
  • Nail Psoriasis
  • Deucravacitinib
  • (no location specified)
Dec 8, 2022

Psoriasis Trial in Germany, Poland, United States (Deucravacitinib, Placebo)

Not yet recruiting
  • Psoriasis
  • Deucravacitinib
  • Placebo
  • Indianapolis, Indiana
  • +3 more
Jul 27, 2022

Healthy Participants Trial in Miami, Austin (Deucravacitinib, Famotidine)

Completed
  • Healthy Participants
  • Miami, Florida
  • +1 more
Feb 24, 2022

Sjögren's Syndrome Trial in Worldwide (Deucravacitinib, Placebo)

Not yet recruiting
  • Sjögren's Syndrome
  • Deucravacitinib
  • Placebo
  • Santa Monica, California
  • +25 more
Jul 19, 2023

Plaque Psoriasis Trial in Worldwide (Deucravacitinib, Placebo matching deucravacitinib)

Recruiting
  • Plaque Psoriasis
  • Deucravacitinib
  • Placebo matching deucravacitinib
  • Sydney, New South Wales, Australia
  • +20 more
Jul 1, 2022

Alopecia Areata Trial in Worldwide (Deucravacitinib, Placebo)

Recruiting
  • Alopecia Areata
  • Deucravacitinib
  • Placebo
  • Irvine, California
  • +22 more
Jan 31, 2023

Palmoplantar Psoriasis, Genital Psoriasis Trial in Worldwide (Deucravacitinib, Placebo)

Not yet recruiting
  • Palmoplantar Psoriasis
  • Genital Psoriasis
  • Deucravacitinib
  • Placebo
  • Birmingham, Alabama
  • +24 more
Sep 12, 2023

Psoriasis Trial in United States (Deucravacitinib, Placebo)

Not yet recruiting
  • Psoriasis
  • Deucravacitinib
  • Placebo
  • Phoenix, Arizona
  • +24 more
Jan 26, 2023

Crohn Disease, Ulcerative Colitis Trial in Worldwide (Deucravacitinib)

Recruiting
  • Crohn Disease
  • Ulcerative Colitis
  • Deucravacitinib
  • Suwanee, Georgia
  • +47 more
Jan 17, 2023

Lupus Erythematosus, Discoid, Lupus Erythematosus, Subacute Cutaneous Trial in Worldwide (Deucravacitinib, Placebo)

Recruiting
  • Lupus Erythematosus, Discoid
  • Lupus Erythematosus, Subacute Cutaneous
  • Deucravacitinib
  • Placebo
  • Los Angeles, California
  • +42 more
Oct 21, 2022

Systemic Lupus Erythematosus Trial in Worldwide (Deucravacitinib, Placebo)

Recruiting
  • Systemic Lupus Erythematosus
  • Deucravacitinib
  • Placebo
  • Anniston, Alabama
  • +88 more
Jan 25, 2023

Systemic Lupus Erythematosus Trial in Worldwide (Deucravacitinib, Placebo)

Recruiting
  • Systemic Lupus Erythematosus
  • Deucravacitinib
  • Placebo
  • La Jolla, California
  • +91 more
Jan 24, 2023

Psoriatic Arthritis Trial in Worldwide (Deucravacitinib, Placebo)

Recruiting
  • Psoriatic Arthritis
  • Deucravacitinib
  • Placebo
  • Jonesboro, Arkansas
  • +127 more
Aug 12, 2022

Psoriatic Arthritis Trial in Worldwide (Deucravacitinib, Placebo, Apremilast)

Recruiting
  • Psoriatic Arthritis
  • Deucravacitinib
  • +2 more
  • Birmingham, Alabama
  • +136 more
Jul 29, 2022